Location: Home
  • search
  • go
  • Relate News
  • 9/24/2014Senior NDRC Drug Price Official under Investigation
  • 9/24/2014Jointown's Haoyaoshi Enters O2O Partnership with Chunyu Yisheng
  • 9/24/2014CFDA Announces OTC Switches of 21 Prescription Drugs
  • 9/24/2014Recent Executive Moves
  • 9/23/2014How Should Foreign Companies Interpret GSK's China Fines And Penalties...
  • 9/23/2014Merck Serono, CSCO Co-founds Oncology Research Fund
  • 9/23/2014Chengdu to Remove Drug Sales Margins in County Level Public Hospitals
  • 9/23/2014Gilead's Emerging Market Deal for HepC Drug Sovaldi Excludes China
  • 9/22/2014IMS: Chinese Hospital Drug Sales Growth Slowed in Q1/2014
  • 9/22/2014Upcoming Event: ChinaTrials 7
  • 9/21/2014Recent Executive Moves
  • 9/19/2014Bayer to Focus Entirely on Life Science Businesses
  • 9/19/2014Financial-related Company News in Brief
  • 9/19/2014Chinese Government Budgets CNY 37.8B for Public Health Services in 201...
  • 9/19/2014Chinese Court Imposes CNY 3 Bln Record Fine on GSK for Bribery
  • 9/19/2014Executive Moves
  • 9/18/2014Spectrum Pharma Licenses China Rights of Oncology Drugs to CASI Pharma
  • 9/18/2014Sino-French Research Team Finds Potential HIV Vaccine
  • 9/18/2014China and India Enter Trade Pact with Pharma Issues Addressed
  • 9/18/2014Guangzhou Baiyunshan Launches Viagra Generic in China
  • 9/17/20143SBio Licenses China Rights of Anticancer from JenKem
  • 9/17/2014Listed Chinese Pharma Companies Expect Earnings Growth in Q3/2014
  • 9/17/2014Denovo Biopharma Acquires Global Rights of Late Stage Oncology Drug Ca...
  • 9/16/2014NHFPC Issues New Policy for Promotion and Administration of Telemedici...
  • 9/16/2014Taiwan Liposome Gains Chinese Approval for Phase II Trials of Anticanc...
  • 9/16/2014China Resources Signs MOU with Nottingham University for Wide-ranging ...
  • 9/16/2014Online Medical Communication Sees Rising Popularity Among Chinese Phys...
  • 9/16/2014MNCs Saw Slowing and Double-digit Growth in China (2013-Q2/2014)
  • 9/16/2014CFDA Publishes List of Excessively-Supplied Drug Products (1st Batch)
  • 9/15/2014CFDA Vice Minister Yin Li Meets Country Head of U.S. FDA China Office
  • Page:406/720 Total number of articles:21589: [First][<<] [404] [405] [406] [407] [408] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group